Publication | Closed Access

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

VaccinationPlasmid Pthr DnaVaccine DevelopmentVaccine TargetHuman RetrovirusImmunologyAntiviral ResponseVirologyEast AfricaVaccinia Virus AnkaraHivPolyvalent VaccineMedicineEpidemiology